Literature DB >> 24960657

Iron excretion in iron dextran-overloaded mice.

Marco Musumeci1, Sonia Maccari1, Alessia Massimi1, Tonino Stati1, Paola Sestili2, Elisa Corritore1, Augusto Pastorelli3, Paolo Stacchini3, Giuseppe Marano1, Liviana Catalano4.   

Abstract

BACKGROUND: Iron homeostasis in humans is tightly regulated by mechanisms aimed to conserve iron for reutilisation, with a negligible role played by excretory mechanisms. In a previous study we found that mice have an astonishing ability to tolerate very high doses of parenterally administered iron dextran. Whether this ability is linked to the existence of an excretory pathway remains to be ascertained.
MATERIALS AND METHODS: Iron overload was generated by intraperitoneal injections of iron dextran (1 g/kg) administered once a week for 8 weeks in two different mouse strains (C57bl/6 and B6D2F1). Urinary and faecal iron excretion was assessed by inductively coupling plasma-mass spectrometry, whereas cardiac and liver architecture was evaluated by echocardiography and histological methods. For both strains, 24-hour faeces and urine samples were collected and iron concentration was determined on days 0, 1 and 2 after iron administration.
RESULTS: In iron-overloaded C57bl/6 mice, the faecal iron concentration increased by 218% and 157% on days 1 and 2, respectively (p<0.01). The iron excreted represented a loss of 14% of total iron administered. Similar but smaller changes was also found in B6D2F1 mice. Conversely, we found no significant changes in the concentration of iron in the urine in either of the strains of mice. In both strains, histological examination showed accumulation of iron in the liver and heart which tended to decrease over time.
CONCLUSIONS: This study indicates that mice have a mechanism for removal of excess body iron and provides insights into the possible mechanisms of excretion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24960657      PMCID: PMC4212028          DOI: 10.2450/2014.0288-13

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  11 in total

Review 1.  Practical management of iron overload.

Authors:  J B Porter
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

2.  Iron-overload cardiomyopathy: evidence for a free radical--mediated mechanism of injury and dysfunction in a murine model.

Authors:  W J Bartfay; E Bartfay
Journal:  Biol Res Nurs       Date:  2000-07       Impact factor: 2.522

3.  Iron excretion in iron-overloaded rats following the change from an iron-loaded to an iron-deficient diet.

Authors:  P S Oates; G P Jeffrey; K A Basclain; C Thomas; E H Morgan
Journal:  J Gastroenterol Hepatol       Date:  2000-06       Impact factor: 4.029

4.  Bone loss caused by iron overload in a murine model: importance of oxidative stress.

Authors:  Jaime Tsay; Zheiwei Yang; F Patrick Ross; Susanna Cunningham-Rundles; Hong Lin; Rhima Coleman; Philipp Mayer-Kuckuk; Stephen B Doty; Robert W Grady; Patricia J Giardina; Adele L Boskey; Maria G Vogiatzi
Journal:  Blood       Date:  2010-06-16       Impact factor: 22.113

Review 5.  Iron imports. IV. Hepcidin and regulation of body iron metabolism.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-02       Impact factor: 4.052

6.  L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy.

Authors:  Gavin Y Oudit; Hui Sun; Maria G Trivieri; Sheryl E Koch; Fayez Dawood; Cameron Ackerley; Mehrdad Yazdanpanah; Greg J Wilson; Arnold Schwartz; Peter P Liu; Peter H Backx
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

7.  Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron.

Authors:  H L Bonkovsky; J F Healey; B Lincoln; B R Bacon; D F Bishop; G H Elder
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

8.  The C57BL/6 genetic background confers cardioprotection in iron-overloaded mice.

Authors:  Marco Musumeci; Sonia Maccari; Paola Sestili; Alessia Massimi; Elisa Corritore; Giuseppe Marano; Liviana Catalano
Journal:  Blood Transfus       Date:  2012-06-28       Impact factor: 3.443

9.  Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model.

Authors:  Gavin Y Oudit; Maria G Trivieri; Neelam Khaper; Taneya Husain; Greg J Wilson; Peter Liu; Michael J Sole; Peter H Backx
Journal:  Circulation       Date:  2004-03-22       Impact factor: 29.690

10.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

View more
  5 in total

1.  Diagnosis of Systemic Diseases Using Infrared Spectroscopy: Detection of Iron Overload in Plasma-Preliminary Study.

Authors:  Leonardo Barbosa Leal; Marcelo Saito Nogueira; Jandinay Gonzaga Alexandre Mageski; Thiago Pereira Martini; Valério Garrone Barauna; Leonardo Dos Santos; Luis Felipe das Chagas E Silva de Carvalho
Journal:  Biol Trace Elem Res       Date:  2021-01-07       Impact factor: 3.738

2.  MFehi adipose tissue macrophages compensate for tissue iron perturbations in mice.

Authors:  Merla J Hubler; Keith M Erikson; Arion J Kennedy; Alyssa H Hasty
Journal:  Am J Physiol Cell Physiol       Date:  2018-05-16       Impact factor: 4.249

3.  Assessment of MR-based R2* and quantitative susceptibility mapping for the quantification of liver iron concentration in a mouse model at 7T.

Authors:  Gregory Simchick; Zhi Liu; Tamas Nagy; May Xiong; Qun Zhao
Journal:  Magn Reson Med       Date:  2018-03-25       Impact factor: 4.668

4.  Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron.

Authors:  Francesca La Carpia; Boguslaw S Wojczyk; Medini K Annavajhala; Abdelhadi Rebbaa; Rachel Culp-Hill; Angelo D'Alessandro; Daniel E Freedberg; Anne-Catrin Uhlemann; Eldad A Hod
Journal:  NPJ Biofilms Microbiomes       Date:  2019-09-24       Impact factor: 7.290

Review 5.  Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients.

Authors:  Hanan Kamel M Saad; Alawiyah Awang Abd Rahman; Azly Sumanty Ab Ghani; Wan Rohani Wan Taib; Imilia Ismail; Muhammad Farid Johan; Abdullah Saleh Al-Wajeeh; Hamid Ali Nagi Al-Jamal
Journal:  Biomedicines       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.